Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Navigate: Correlations HPO
There is one clinical trial.
This study will use a digital platform to longitudinally track comprehensive information including patient self-report as well as data that describe the process and outcome of care in the electronic medical record (EMR) of a large representative sample of patients under investigation for SARSCOV2. The objective is to generate knowledge rapidly using digital tools and collaborative sciences to produce real-time data, analysis, and reporting compared to more traditional approaches. An additional goal is to promote an open science approach whereby scientists, with proper approvals and in line with the permissions granted by the participants, have the opportunity to work with data in ways that protects individual privacy but promotes rapid dissemination and implementation of knowledge.
Description: determine the risk of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in those with symptoms of SARSCOV2 infection with vs. without a positive confirmatory test.
Measure: Incident myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Time: 18 months post enrollmentDescription: Count of ambulatory care and/or ED visits post enrollment as obtained from the EMR
Measure: Ambulatory care and/or ED visits post enrollment Time: 18 months post enrollmentDescription: Count of hospitalizations post enrollment as obtained from the EMR
Measure: Hospitalizations post enrollment Time: 18 months post enrollmentDescription: death during hospital admission as determined by data from the EMR
Measure: Death during hospital admission Time: 18 months post enrollmentDescription: Hospital-free survival as determined by data from the EMR
Measure: Hospital-free survival Time: 18 months post enrollmentDescription: ICU-free survival as determined by data from the EMR
Measure: ICU-free survival Time: 18 months post enrollmentAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports